Current status of genetic discoveries in migraine: Familial hemiplegic migraine and beyond

Current Opinion in Neurology

Volumn 11, Issue 3, 1998, Pages 211-216

  Gardner, Kathy ^a   Hoffman, Eric P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; DOPAMINE 2 RECEPTOR;

ATAXIA; CHROMOSOME 1; CHROMOSOME 19P; EPILEPSY; FAMILIAL DISEASE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEMIPLEGIA; HUMAN; MIGRAINE; NONHUMAN; REVIEW;

ANIMALS; EPILEPSY; GENETICS, POPULATION; HEMIPLEGIA; MICE; MIGRAINE DISORDERS; MITOCHONDRIA; MUTATION; RECEPTORS, DOPAMINE D2; TENSION-TYPE HEADACHE;

EID: 0031809681     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199806000-00004     Document Type: Review

References (50)

1. Clark J. On recurrent motor paralysis in migraine. Br Med J 1910; 1:1534-1538.
2. Bradshaw P, Parsons M. Hemiplegic migraine, a clinical study. Quarterly J Med 1965; 34:65-68.
3. Gastaut JL, Yermenos E, Bonnefoy M, Cros D. Familial hemiplegic migraine: EEG and CT scan study of two cases. Annals of Neurology 1981; 10:392-395.
4. Heyck H. Varieties of hemiplegic migraine. Headache 1973; 12:135-142
5. Parsonage M. In: Pearce J (editor). Modern topics in migraine. EEG changes in migraine. 72 Bristol: Arrowsmith 1975.
6. Ducros A, Joutel A, Vahedi K, Cecillon M, Ferreira A, Bernard E, et al. •• Mapping of a second locus for familial hemiplegic migraine to 1q21-23 and evidence of further genetic heterogeneity. Ann Neurol 1997; 42:885-890. A new locus at Chr1q21-23 was reported in three French families with hemiplegic migraine based on a 2-point LOD score of 4.21, θ=0.07 among the 24 affected individuals. Two patients had an attack-related seizure and haplotype analysis suggested one phenocopy and five nonpenetrants, including a discordant twin pair. The families were clinically normal otherwise. Four other families did not link to the Chr1q21-23 or Chr19 FHM loci, demonstrating further genetic heterogeneity.
7. Joutel A, Tournier-Lasserve E, Bousser MG. [Hemiplegic migraine] [Review] [French]. Press Medicate 1995; 24:411-414.
8. Terwindt GM, Ophoff RA, Haan J, Frants RR, Ferrari MD. Familial hemiplegic migraine: a clinical comparison of families linked and unlinked to chromosome 19.DMG RG. Cephalalgia 1996; 16:153-155
9. + channel gene CACN1 A4. Cell 1996; 87:543-552.
10. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, •• et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1 A-voltage-dependent calcium channel. Nat Genet 1997; 15:62-69. A mildly expanded CAG repeat in the 3 translated end of three of the six isoforms for the brain expressed CACNL14A calcium channel was found to be associated with a late onset, progressive ataxia called SCA6. The SCA6 expansion disorder is allelic with hemiplegic migraine and episodic ataxia-2. All three disorders are associated with different types of mutations in the CACNL1A4 gene.
11. Jodice C, Mantuano E, Veneziano L, Trettel F, Sabbadini G, Calardinello I, • et al. Episodic ataxia type 2 (Ea2) and spinocerebellarataxia type 6 (Sca6) due to cag repeat expansion in the cacnala gene On Chromosome 19p. Hum Mol Genet 1997; 6:1973-1978. One SCA6 family with a CAG repeat size of 23 in the Chr19p CACNL1A4 gene presented with intrafamilial variability of phenotype and no other mutations in the coding sequence of the gene. Another SCA6 family was reported to have an episodic ataxia phenotype in a single member with CAG expansion of 20, and a progressive ataxia only was seen in a member with 25 allele expansion. The authors emphasized clinical variability and the potential for phenotypic overlap between SCA6 and EA-2.
12. Hagiwara S, Byerly L. Calcium channel [review] Ann Rev Neurosci 1981; 4:69-125.
13. + channels [review] Trends Pharmacol Sci 1991; 12:349-354.
14. + channels in mammalian central neurons [review] Trends Neurosci 1995; 18:89-98.
15. + channel types coexist to regulate synaptosomal neurotransmitter release. Proc Natl Acad Sci USA 1993; 90:9518-9522.
16. Turner TJ, Adams ME, Dunlap K. Calcium channels coupled to lutamate release identified by omega-Aga-IVA. Science 1992; 258:310-3.
17. Harvey J, Wedley S, Findlay JD, Sidell MR, Pullar IA. Omega-Agatoxin Iva identifies a single calcium channel subtype which contributes to the potassium-induced release of acetylcholine, 5-hydroxytryptamine, dopamine, gamma-aminobutyric acid and glutamata from rat brain slices. Neuropharmacology 1996; 35:385-392.
18. Bagdy E, Harsing LG, Jr. The role of various calcium and potassium channels in the regulation of somatodendritic serotonin release. Neurochemical Research 1995; 20:1409-1415.
19. Racke K, Reimann A, Schworer H, Kilbinger H. Regulation of 5-HT release from enterochromaffin cells [review] Behav Brain Res 1996; 73:83-87.
20. Codignola A, Tarroni P, Clementi, F, Pollo A, Lovallo M, Carbone E, et al. Calcium channel subtypes controlling serotonium release from human small cell lung carcinoma cell lines. Journal of Biological Chemistry 1993; 268:26240-26247.
21. Gardner K, Barmada MM, Ptacek LJ, Hoffman EP. A New Locus. For •• Hemiplegic Migraine Maps to Chromosome 1q31. Neurology 1997; 49:1231-1238. A new locus for hemiplegic migraine at Chr1q31 was described in a four-generation family with stereotypic attacks and no cerebellar signs, in a candidate region for a brain expressed calcium channel. The multipoint LOD score was 3.32 near marker D1S249, using a penetrance of 80% and phenocopy rate of 1/50. A single phenocopy and two nonpenetrant family members who carried the disease haplotype were described.
22. Gardner F, Badger J, Barmada MOCJ, Hoffman E. Refinement of the chromosome lq31 locus for hemiplegic migrane. Lippincott Raven Publishers, New York, 1998 (in press).
23. Fletcher CF, Lutz CM, TN, OS, Shaughnessy JD Jr, Hawkes R, Frankel WL, et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996; 87:607-617.
24. + channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (1 h) mouse. Cell 1997; 88:385-392.
25. Patil N, Cox DR, Bhat D, Faham M, Myers RM, Peterson AS. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation [see comments]. Nat Genet 1995; 11:126-129.
26. Bickerstaff E. Basilar artery migraine. Lancet 1961; 15-17.
27. Donnet A, Bartolomei F. Migraine with visual aura and photosensitive epileptic seizure. Epilepsia 1997; 38:1032-1034.
28. Marks DA, Ehrenberg BL. Migraine-related seizures in adults with epilepsy. with EEG correlation. Neurology 1993; 43:2476-2483.
29. Singh N, Charlier C, Stauffer D, D. Font B, Leach R, Melis R, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1988; 18:25-29.
30. Charlier C, Singh N, Ryan S, Lewis T, Reus B, Leuch R, et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998; 18:53-55.
31. Terwindt GM, Ophoff RA, Lindhout D, Haan J, Halley DJJ, Sand Kuijl LA, • et al. Partial Cosegregation of Familial Hemiplegic Migraine and a Benign Familial Infantile Epileptic Syndrome. Epilepsia 1997; 38:915-921. Partial segregation of a rare form of hemiplegic migraine and an early childhood epilepsy, BIFC, was described in a three generation pedigree. Migraine without aura only was common in many members. Linkage to the Chr19p and benign neonatal convulsions loci on Chr20 and Chr8 were excluded and an affected only analysis found mild evidence for cotransmission of the two disorders.
32. Stewart WF, Staffa J, Lipton RB, Ottmann R. Familial risk of migraine: •• a population-based study. Ann Neurol 1997; 41:166-172. A large population-based study with case-controls and direct interviews found an overall relative risk of 1.5 for migraine, which is lower than previous reports from similar studies. Relative risk in migraine with aura was only slightly higher in family members of probands with migraine, also in contrast to a previous study. Importantly, disability with migraine in the proband was associated with a statistically significant higher relative risk of 2.17. Gender differences in migraine risk could not be adequately assessed.
33. Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine [see comments]. BMJ 1995; 311:541-544.
34. Ulrich V, Russell MB, Ostergaard S, Olesen J. Analysis of 31 Families with an apparently autosomal-dominant transmission of migraine with aura in the Nuclear Family. Am J Med Genet 1997; 74:395-397.
35. Ostergaard S, Russell MB, Bendtsen L, Olesen J. Comparison of first degree relatives and spouses of people with chronic tension headache. BMJ 1997; 314:1092-1093.
36. Ulrich V, Russell MB, Jensen R, Olesen J. A comparison of tension type headache in migraineurs and in non-migraineurs: a population-based study. Pain 1996; 67:501-506.
37. Merikangas K, Tierney C, Martin N, Heath A, NR. In: Rose C (editor). New Advances in Headache Research. Genetics of migraine in the Australian twin registry, 27-28 Smith-Gordon and Company, Ltd. London, 1994 pp 27-28.
38. Tierney C, Merikangas K, Martin N, Heath A. The genetics of headache symptoms in the Australian twin registry [abstract]. Am J Hum Genet 1994; 55:A158.
39. Peroutka SJ. Dopamine and migraine [review]. Neurology 1997; 49:650-656.
40. Peroutka SJ, Wilhoit T, Jones K. Clinical susceptibility to migraine with •• aura is modified by dopamine D2 receptor (DRD2) Ncol alleles. Neurology 1997; 49:201-206. A polymorphism in the dopamine DRD2 receptor was found to be significantly associated with migraine with aura (P=0.005) among 250 patients compared with control individuals. It is the first to establish a link between regular migraine and candidate or 'susceptibility' loci. other than the Chr19p hemiplegic migraine locus.
41. Buchwalder A, Welch SK, Peroutka SJ. Exclusion of 5-HT2A and 5-HT2C receptor genes as candidate genes for migraine. Headache 1996; 36:254-258.
42. Nyholt DR, Curtain RP, Gaffney PT, Brimage P, Goadsby PJ, Griffiths LR. Migraine association and linkage analyses of human 5-hydroxytryptamine (5HT2A) receptor gene. Cephalalgia 1996; 16:463-467.
43. Burnet PW, Harrison PJ, Goodwin GM, Batter by S, Ogilvie AD, Oleson J, et al. Allelic variation in the serotonin 5-HT2C receptor gene and migraine. Neuroreport 1997; 8:2651-2653.
44. Griffiths LR, Nyholt DR, Curtain RP, Goadsby PJ, Brimage PJ. Migraine association and linkage studies of an endothelial nitric oxide synthase (NOS3) gene polymorphism. Neurology 1997; 49:614-617.
45. Shimomura T, Kitano A, Marukawa, Hea. Mutation in platelet mitochondrial gene in patients with migraine. Cephalagia 1995; 15:10.
46. Russell MB, Diamant M, Norby S. Genetic heterogeneity of migraine with and without aura in Danes cannot be explained by mutation in mtDNA nucleotide pair 11084. Acta Neurol Scand 1997; 96:171-173.
47. Shimomura T, Kitano A, Marukawa H, Mishima K, Isoe K, Adachi Y, et al. Point mutation in platelet mitochondrial tRNA (Leu(UUR)) in patient with cluster headache [letter: comment]. Lancet 1994; 344:625.
48. Odawara M, Tomaoka A, Mizusawa H, Yamashita K. A case of cluster headache associated with mitochondrial DNA deletions [letter]. Muscle Nerve 1997; 20:394-395.
49. Montagna P, Lodi R, Cortelli P, Pierangeli G, Iotti S, Cevoli S, et al. Phosphorus magnetic resonance spectroscopy in cluster headache. Neurology 1997; 48:113-118.
50. Welch KM, Ramadan NM. Mitchondria, magnesium and migraine [review] Journal of the Neurological Sciences 1995; 134:9-14.